Mayer,
An additional relevant example would be to discuss the evidence informing the
use of low-molecular weight heparin vs warfarin vs ASA in hip and/or knee
replacement surgery.
A systematic review that will serve as a good starting point can be found at
www.ccohta.ca
Best regards,
Janet E. Martin, BScPharm, PharmD
Project Leader
Evidence-Based Prescribing Initiative
London Health Sciences Centre
London, Ontario
Canada N6A 4G5
tel: (519) 685-8500 ext 77814
fax: (519) 667-6811
[log in to unmask]
>>> Mayer Brezis <[log in to unmask]> 11/12/01 03:49PM >>>
I'm preparing a lecture on EBM to orthopedic surgeons. Any suggestions
for good demonstration of EBM in this field (I already noted the
negative Cochrane Review on back surgery)? Also, any good example in
this field of manipulation of guidelines by the industry (like the
remarkable example of tPA in stroke, Genentek speaking via the American
Heart Association)? Thanks.
Mayer Brezis
|